Description: Item 9 Labs Corp. develops and manufactures marijuana products and proprietary delivery platforms. The company's products include Air Allergy, a discreet personal filter, which protects from irritating airborne allergens; and Air Sleep/Snore, a drug-free relief for congestion and snoring caused by nasal breathing difficulties. It focuses on offering its products to sleeping partners, individuals with chronic sinus issues, individuals that suffer from chronic sleep disorders, and individuals with allergies in the United States, Canada, Asia, and the European Union. The company was founded in 2010 and is headquartered in Scottsdale, Arizona.
Home Page: www.item9labscorp.com
2727 North 3rd Street
Phoenix,
AZ
85004
United States
Phone:
833 867 6337
Officers
Name | Title |
---|---|
Mr. Michael Weinberger | CEO & Director |
Mr. Robert E. Mikkelsen | Sec., Treasurer & CFO |
Mr. Christopher Leland Wolven | Chief Operating Officer |
Mr. Mike Keskey II | Gen. Counsel |
Ms. Jayne Levy | Sr. VP of Communications |
Kyle Jennings | VP of Marketing |
Mr. Mark Busch | Sr. VP of Corp. Devel. |
Mr. Cory Carter | Sr. VP of Cultivation |
Exchange: OTCQX
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0.2833 |
Price-to-Sales TTM: | 0.9485 |
IPO Date: | |
Fiscal Year End: | September |
Full Time Employees: | 103 |